Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Toxicological information

Acute Toxicity: oral

Currently viewing:

Administrative data

Endpoint:
acute toxicity: oral
Type of information:
experimental study
Adequacy of study:
weight of evidence
Reliability:
2 (reliable with restrictions)
Rationale for reliability incl. deficiencies:
study well documented, meets generally accepted scientific principles, acceptable for assessment
Justification for type of information:
Data is from peer- reviewed journal

Data source

Reference
Reference Type:
publication
Title:
Mutagenic Activity of chemical carcinogens and Related Compounds in the inteaperitoneal Host-Mediated Assay
Author:
Vincent F. Simmon, Herbert S. Rosenkranz, Errol Zeiger, and Lionel A. Poirier
Year:
1979
Bibliographic source:
J NATL CANCER INST, VOL. 62, NO.4, APRIL 1979

Materials and methods

Test guideline
Qualifier:
according to guideline
Guideline:
other: as below
Principles of method if other than guideline:
Acute oral toxicity of 4-Aminoazobenzene in mice
GLP compliance:
not specified
Test type:
other: not specified
Limit test:
no

Test material

Constituent 1
Reference substance name:
4-Aminoazobenzene
Cas Number:
60-09-3
Molecular formula:
C12H11N3
IUPAC Name:
4-Aminoazobenzene
Details on test material:
- Name of test material (as cited in study report): 4-Aminoazobenzene
- Molecular formula (if other than submission substance): C12H11N3
- Molecular weight (if other than submission substance): 197.24 g/mole
- Substance type: Organic
Specific details on test material used for the study:
- Name of test material (as cited in study report): 4-Aminoazobenzene
- Molecular formula (if other than submission substance): C12H11N3
- Molecular weight (if other than submission substance): 197.24 g/mole
- Substance type: Organic

Test animals

Species:
mouse
Strain:
Swiss Webster
Sex:
male
Details on test animals or test system and environmental conditions:
- Source: Division of Cancer Treatment, Mammalian Genetics and Animal Production Section, National Cancer Institute
- Age at study initiation:
- Weight at study initiation: 25-30 g.
- Fasting period before study: No data available
- Housing: No data available
- Diet (e.g. ad libitum): Animals were fed laboratory chow ad libitum until they were treated with the test chemicals.
- Water (e.g. ad libitum): No data available
- Acclimation period: No data available

Administration / exposure

Route of administration:
oral: unspecified
Vehicle:
not specified
Details on oral exposure:
No data available
Doses:
2-5,500 mg/kg (generally 125 mg/kg)
No. of animals per sex per dose:
No data available
Control animals:
not specified
Details on study design:
- Duration of observation period following administration: 24 hour
- Frequency of observations and weighing: No data available
- Necropsy of survivors performed: No data available
- Other examinations performed: Mortality was observed.
Statistics:
No data available

Results and discussion

Preliminary study:
No data available
Effect levels
Sex:
male
Dose descriptor:
LD50
Effect level:
483 mg/kg bw
Based on:
test mat.
Remarks on result:
other: 50 % mortality observed
Mortality:
50 % mortality was observed in treated mice
Clinical signs:
other: No data available
Gross pathology:
No data available
Other findings:
No data available

Applicant's summary and conclusion

Interpretation of results:
Category 4 based on GHS criteria
Conclusions:
LD50 was considered to be 483 mg/kg/day when male Swiss-Webster mice were treated with 4-Aminoazobenzene orally.
Executive summary:

In acute toxicity study,male Swiss-Webster mice were treated with 4-Aminoazobenzene in the concentration of 2-5,500 mg/kg (generally 125 mg/kg) orally. 50 % mortality was observed in treated mice. Therefore, LD50 was considered to be 483 mg/kg/day when male Swiss-Webster mice were treated with 4-Aminoazobenzene orally.